Retinopathy of Prematurity (ROP) Active Not Recruiting Phase 2 Trials for Mecasermin rinfabate (DB14751)

Also known as: ROP - Retinopathy of Prematurity / Retinopathy of Prematurity / Retrolental fibroplasia / Retinopathy of prematurity (disorder) / Retinopathy of prematurity NOS / Retrolental fibroplasia (disorder)

IndicationStatusPhase
DBCOND0046296 (Retinopathy of Prematurity (ROP))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03253263A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature InfantsPrevention